Showing results (71-80 of 95) with videos related to
Sort By:
Pageof 10
Clinical Toxicology (Philadelphia, Pa.)|February 23, 2010
Escitalopram causes fewer seizures in human overdose than citalopramZeynep Yilmaz, Alessandro Ceschi, Christine Rauber-Lüthy, et al.Frontiers in Immunology|November 15, 2021
GPR Expression in Intestinal Biopsies From SCT Patients Is Upregulated in GvHD and Is Suppressed by Broad-Spectrum AntibioticsSakhila Ghimire, Daniela Weber, Katrin Hippe, et al.Haematologica|June 1, 2023
Intestinal IgA-positive plasma cells are highly sensitive indicators of alloreaction early after allogeneic transplantation and associate with both graft-versus-host disease and relapse-related mortalityLucia Scheidler, Katrin Hippe, Sakhila Ghimire, et al.Bone Marrow Transplantation|March 19, 2025
αß T-cell depleted haploidentical stem cell transplantation for pediatric and young adult patients with transfusion-dependent thalassemiaKatharina Kleinschmidt, Gina Penkivech, Anja Troeger, et al.Nature Communications|April 15, 2024
Donor regulatory T cells rapidly adapt to recipient tissues to control murine acute graft-versus-host diseaseDavid J Dittmar, Franziska Pielmeier, Nicholas Strieder, et al.Blood|March 28, 2014
The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulationsChristian Schmidl, Leo Hansmann, Timo Lassmann, et al.Blood|January 27, 2007
Inhibitory effect of tumor cell-derived lactic acid on human T cellsKarin Fischer, Petra Hoffmann, Simon Voelkl, et al.Nature Communications|February 27, 2020
Author Correction: Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1Julia Minderjahn, Andreas Schmidt, Andreas Fuchs, et al.Nature Communications|January 23, 2020
Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1Julia Minderjahn, Andreas Schmidt, Andreas Fuchs, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 19, 2025
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorderHelena Hansmann, Chiara Henkel, Matthias A Fante, et al.Pageof 10